PeaMAX addresses these challenges head-on. Through targeted gene editing, BetterSeeds has optimised PeaMAX for mechanised.
BetterSeeds announced that PeaMAX, the company’s innovative gene-edited cowpea, has been granted approval for commercialisation in the United States by the USDA. This marks a historic moment, as PeaMAX is not only a game-changer for American agriculture but also the world’s first-ever gene-edited cowpea.
Cowpea, a high-protein legume lauded for its drought and heat tolerance, has traditionally faced limitations for large-scale production. Its long growing season and unsuitability for mechanized harvesting have hindered its widespread adoption. PeaMAX addresses these challenges head-on. Through targeted gene editing, BetterSeeds has optimised PeaMAX for mechanised harvesting using existing soybean growing machinery. Additionally, the improved variety boasts a shortened growing season, making it ideal for summer cultivation by soybean growers in the USA, Brazil, and Argentina.
This USDA approval marks a significant milestone for PeaMAX and paves the way for its introduction to the American market. BetterSeeds believes PeaMAX represents the next generation of cowpea, empowering soybean growers with a high-profit legume option for seasons where traditional soybean cultivation faces challenges due to climate change.
Key benefits of PeaMAX:
Suitable for mechanized harvesting: Integrates seamlessly with existing soybean harvesting equipment.
Shorter growing season: Ideal for summer planting in key soybean growing regions.
High protein content: Provides a valuable source of plant-based protein.
Drought and heat tolerant: Thrives in challenging climates.
BetterSeeds is confident that PeaMAX will empower farmers and revolutionize cowpea production. The company looks forward to bringing this innovative new option to soybean growers across the USA.
